Urgent Alert: Is Your Blood Pressure Medication Safe?
If you're among the thousands relying on blood pressure medication, this news is crucial: the FDA has issued a recall of Ziac, a commonly prescribed drug. This recall is due to a contamination issue, and it's essential to know if your medication is affected.
This recall, announced on December 9, 2025, involves over 11,100 bottles of Ziac. The issue? Cross-contamination with another medication, specifically traces of ezetimibe, a drug used to treat high cholesterol. The manufacturer, Glenmark Pharmaceuticals, based in New Jersey, is handling the recall.
But here's where it gets controversial... While the FDA has classified this as a Class III recall, meaning it's "not likely to cause adverse health consequences," it's still a cause for concern. The presence of an unintended drug, even in trace amounts, raises questions about the integrity of the medication and the potential for unforeseen effects, especially for those with cholesterol issues.
So, what exactly is being recalled?
The recall affects Ziac tablets containing bisoprolol fumarate and hydrochlorothiazide. The specific dosages involved are 2.5 mg and 6.25 mg. The affected products come in various bottle sizes, including:
- 30-count bottles: NDC 68462-878-30
- 100-count bottles: NDC 68462-878-01
- 500-count bottles: NDC 68462-878-05
Check Your Medicine Cabinet!
Carefully examine your Ziac medication. The recall includes specific lot numbers. Here's a list to help you check:
- Lot No. 17232401, exp 11/2025
- Lot No. 17240974, exp 05/2026
- Lot No. 17232401, exp 11/2025
- Lot No. 17240974, exp 05/2026
- Lot No. 17232401, exp 11/2025
- Lot No. 17240974, exp 05/2026
If your medication matches these details, the FDA advises contacting your healthcare provider before taking any further doses. It's always best to err on the side of caution when it comes to your health.
And this is the part most people miss...
The recall was initially announced on November 21, 2025, but officially classified as a Class III recall on December 1. This timeline highlights the importance of staying informed about potential medication issues. It also raises questions about how quickly such information reaches the public and how effectively it is disseminated.
Final Thoughts
This recall serves as a reminder of the importance of vigilance when it comes to our medications. Always check for recall notices, and don't hesitate to consult with your healthcare provider if you have any concerns. This situation may raise questions about the safety and quality control of pharmaceuticals. Do you think the current system is adequate? Share your thoughts and experiences in the comments below. Your insights are valuable!
